Impact Factor 3.9 | CiteScore 4.3
More on impact ›
in Medicine |
|
Submit your manuscript
Scope
The birth of a new medical journal is always exciting and at the same time a great challenge. In particular, in pathology, in the recent years we are witnessing great changes that involve not only the technical aspects, but also the aims and the mission of our discipline. In this context, a new journal of pathology has to be not only a mere witness of this new wind, but must also perform an active role in the education of a new generation of pathologists through the reporting of high quality scientific observations and their active dissemination in the era of Web 2.0. Today, molecular pathology plays an increasing important role in most academic and many general practice departments.
Together with data derived from human genome project and striking technological improvements, the study of disease by means of molecular methods and the application of this knowledge to clinical diagnosis and prognosis are reshaping both biomedical research and general medical practice with a growing emphasis on personalized medicine. Furthermore, the exploding increase of high-throughput molecular techniques is also shifting the general approach to research from the traditional hypothesis-driven science toward a more demanding hypothesis-generating science.
On the other hand, the advent of molecular pathology does not mean the end for morphology–based pathology, which still remains the central core of our daily work. The Pathology section of Frontiers of Medicine aims to explore the scientific basis of human pathology by the publication of high quality research regarding diagnostic, prognostic and predictive topics in pathology. Evidence–based pathology will represent an important prerequisite. In the era of “stratified” and personalised medicine, manuscripts dealing with biomarkers studies are given high priority. Original manuscripts and review articles in the broad area of translational as well as basic research relevant to human clinical disease and exploring the mechanism and etiology of disease processes are also welcome. Clinicopathological case reports, including cases of autoptic pathology, are considered if they advance our understanding of pathophysiology and/or diagnostic practice of disease.
Indexed in: PubMed, PubMed Central (PMC), Scopus, Google Scholar, DOAJ, CLOCKSS
PMCID: all published articles receive a PMCID
Pathology welcomes submissions of the following article types: Brief Research Report, Case Report, Clinical Trial, Correction, Editorial, General Commentary, Methods, Mini Review, Original Research, Perspective, Review, Study Protocol and Systematic Review.
All manuscripts must be submitted directly to the section Pathology, where they are peer-reviewed by the Associate and Review Editors of the specialty section.
Frontiers Editorial Office
Avenue du Tribunal Fédéral 34
CH – 1005 Lausanne
Switzerland
Tel +41(0)21 510 17 40
Fax +41 (0)21 510 17 01
Frontiers Support
Tel +41(0)21 510 17 10
Fax +41 (0)21 510 17 01
support@frontiersin.org
There are no results to display.
Click on any of the keywords to find further editors related to it.
- Article(s) found
- Latest
- Most viewed
This section has no articles.
There are no articles to display. Please try changing the filters.
- Research Topic(s) found
- Latest
- Most viewed
Contact Editorial Office
Avenue du Tribunal Fédéral 34
CH – 1005 Lausanne
Switzerland
Tel +41(0)21 510 17 40
Fax +41 (0)21 510 17 01
For all queries regarding manuscripts in Review and potential conflicts of interest, please contact medicine.editorial.office@frontiersin.org
For queries regarding Research Topics, Editorial Board applications, and journal development, please contact medicine@frontiersin.org
Tel +41(0)21 510 17 10
Fax +41 (0)21 510 17 01
For technical issues, please visit our Frontiers Help Center, or contact our IT HelpDesk team at support@frontiersin.org